EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cancer Epidemiology in Albania: Insights, Challenges, and Future Directions

Jona Prifti, Carmelo Pozzo, Erlin Najtellari, Pier Paolo Piccaluga

Journal of Cancer Biomoleculars and Therapeutics · 2025

DOI: 10.62382/jcbt.v2i3.65 ↗
AbstractBibliografische Angaben

Abstract

Background: Cancer is a major cause of morbidity and mortality worldwide. While Albania historically reports a lower cancer incidence than Western Europe, its mortality-to-incidence ratio remains high, suggesting challenges in early detection and treatment access. Methods: We analyzed data from global and regional cancer databases, national health reports, and literature sources, comparing Albania’s cancer trends with neighboring Balkan countries. The study examined incidence, mortality, risk factors, and screening programs. Results: Albania’s cancer incidence rate remains lower than the European average, but its mortality rate is disproportionately high. Lung cancer remains the most prevalent, linked to high smoking rates, while breast, stomach, colorectal, and bladder cancers are also significant. Limited national screening programs, late-stage diagnoses, and healthcare disparities contribute to this trend. A major challenge is the lack of a national cancer registry, leading to underreporting and data fragmentation. Conclusion: Strengthening Albania’s cancer registry, expanding screening programs, and improving oncologic care infrastructure are crucial. Future efforts should focus on cost-effective prevention strategies, improved data collection, and regional collaborations.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →